Genetic Deletion of Soluble Epoxide Hydrolase Attenuates Inflammation and Fibrosis in Experimental Obstructive Nephropathy

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Score</td><td align="center">Degree of sclerosis</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">0</td><td align="center">Normal glomerulus</td></tr><tr><td align="left">1</td><td align="center">25%</td></tr><tr><td align="left">2</td><td align="center">25–50%</td></tr><tr><td align="left">3</td><td align="center">50–75%</td></tr><tr><td align="left">4</td><td align="center">&gt;75%</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Microscopy assessment of histological changes in UUO-induced glomerulosclerosis.

Mediators of Inflammation

tab2

Table 2

Table 2: Genetic Deletion of Soluble Epoxide Hydrolase Attenuates Inflammation and Fibrosis in Experimental Obstructive Nephropathy 